Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is a novel approach for canine cancer therapy. Here we describe, for the first time, the characterization and the use of VACV strain GLV-5b451 expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Viruses
Main Authors: Adelfinger, Marion, Bessler, Simon, Frentzen, Alexa, Cecil, Alexander, Langbein-Laugwitz, Johanna, Gentschev, Ivaylo, Szalay, Aladar A.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517140/
https://ncbi.nlm.nih.gov/pubmed/26205404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v7072811
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares